Thymine DNA Glycosylase-regulated TAZ Promotes Radioresistance by Targeting Nonhomologous End Joining and Tumor Progression in Esophageal Cancer

Overview

Journal Cancer Sci

Specialty Oncology

Date 2020 Aug 19

PMID 32808385

Citations 9

Authors

Wei Zhou

Lin Zhang

Pengxiang Chen

Song Li

Yufeng Cheng

Affiliations

Soon will be listed here.

Abstract

Radiation resistance is a major cause of esophageal cancer relapse or metastasis. Transcriptional coactivator with PDZ binding domain (TAZ) is a final effector of the Hippo signaling pathway and plays critical roles in several types of cancer, but how it participates in the progression and radiation resistance of esophageal cancer remains unclear. Here, we revealed that TAZ was the strongest prognostic factor among Hippo pathway members. Overexpression of TAZ predicted poor outcome and adverse pathological features. In cell and animal models, TAZ facilitated cell proliferation, motility, and radiation resistance. Additionally, TAZ promoted expression of nonhomologous end joining (NHEJ)-related genes, which are the main contributors to repair irradiation-induced DNA breaks and result in radiation resistance. Amplification of the TAZ gene occurred in 2.5%-3.2% of esophageal cancers. In addition, the CpG islands of the TAZ gene were demethylated in esophageal cancer under thymine DNA glycosylase (TDG) regulation. Knockdown of TDG inhibited cell growth, motility, and radiation resistance, which were overridden by TAZ overexpression. Collectively, these findings suggest that the TDG/TAZ/NHEJ axis is a critical player in esophageal cancer progression and radiation resistance, as well as a potential target for radiotherapy.

Citing Articles

Single-Cell Sequencing Reveals the Role of Radiation-Induced Stemness-Responsive Cancer Cells in the Development of Radioresistance.

Shi Z, Hu C, Liu J, Cheng W, Chen X, Liu X Int J Mol Sci. 2025; 26(4).

PMID: 40003899 PMC: 11855645. DOI: 10.3390/ijms26041433.

Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).

Taylor J, Dubois F, Bergot E, Levallet G Int J Oncol. 2024; 65(1).

PMID: 38785155 PMC: 11155713. DOI: 10.3892/ijo.2024.5656.

Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance.

Bentaberry-Rosa A, Nicaise Y, Delmas C, Gouaze-Andersson V, Cohen-Jonathan-Moyal E, Seva C Cancers (Basel). 2024; 16(1).

PMID: 38201456 PMC: 10778311. DOI: 10.3390/cancers16010027.

Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside.

Liu X, Wang Y, Chen B, Chan W, Mui C, Cheung A Biomedicines. 2022; 10(10).

PMID: 36289774 PMC: 9599207. DOI: 10.3390/biomedicines10102512.

DNA repair pathways as a novel therapeutic strategy in esophageal cancer: A review study.

Kheyrandish M, Mostafa Mir S, Sheikh Arabi M Cancer Rep (Hoboken). 2022; 5(11):e1716.

PMID: 36147024 PMC: 9675361. DOI: 10.1002/cnr2.1716.

References

Higashi T, Hayashi H, Ishimoto T, Takeyama H, Kaida T, Arima K . miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. Br J Cancer. 2015; 113(2):252-8. PMC: 4506379. DOI: 10.1038/bjc.2015.170. View

Yuan J, Xiao G, Peng G, Liu D, Wang Z, Liao Y . MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ. Biochem Biophys Res Commun. 2014; 457(2):171-6. DOI: 10.1016/j.bbrc.2014.12.078. View

Zhang L, Yang S, Chen X, Stauffer S, Yu F, Lele S . The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells. Mol Cell Biol. 2015; 35(8):1350-62. PMC: 4372700. DOI: 10.1128/MCB.00102-15. View

Matsumoto Y, La Rose J, Kent O, Wagner M, Narimatsu M, Levy A . Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. J Clin Invest. 2016; 126(12):4482-4496. PMC: 5127668. DOI: 10.1172/JCI87802. View

Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X . A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014; 25(2):166-80. DOI: 10.1016/j.ccr.2014.01.010. View

Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, Nakagawa O . Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun. 2005; 339(2):533-9. DOI: 10.1016/j.bbrc.2005.10.214. View

Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A . Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell. 2011; 146(1):67-79. PMC: 3230223. DOI: 10.1016/j.cell.2011.06.020. View

Zanconato F, Cordenonsi M, Piccolo S . YAP/TAZ at the Roots of Cancer. Cancer Cell. 2016; 29(6):783-803. PMC: 6186419. DOI: 10.1016/j.ccell.2016.05.005. View

Zhou X, Lei Q . Regulation of TAZ in cancer. Protein Cell. 2016; 7(8):548-61. PMC: 4980330. DOI: 10.1007/s13238-016-0288-z. View

10.

Cortazar D, Kunz C, Selfridge J, Lettieri T, Saito Y, MacDougall E . Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature. 2011; 470(7334):419-23. DOI: 10.1038/nature09672. View

11.

Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F . VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res. 2014; 24(3):331-43. PMC: 3945886. DOI: 10.1038/cr.2014.10. View

12.

Pan D . The hippo signaling pathway in development and cancer. Dev Cell. 2010; 19(4):491-505. PMC: 3124840. DOI: 10.1016/j.devcel.2010.09.011. View

13.

Zuo Q, Zhang R, Li B, Zhao Y, Zhuang Y, Yu T . MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ. Cell Death Dis. 2015; 6:e1623. PMC: 4669771. DOI: 10.1038/cddis.2014.573. View

14.

Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J . Thymine DNA glycosylase as a novel target for melanoma. Oncogene. 2019; 38(19):3710-3728. PMC: 6563616. DOI: 10.1038/s41388-018-0640-2. View

15.

Murakami M, Nakagawa M, Olson E, Nakagawa O . A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci U S A. 2005; 102(50):18034-9. PMC: 1312418. DOI: 10.1073/pnas.0509109102. View

16.

Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo M, Dar N . International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol. 2017; 28(9):2086-2093. PMC: 5834011. DOI: 10.1093/annonc/mdx279. View

17.

Zhao Y, Chen S . Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance. Curr Drug Targets. 2019; 20(9):891-902. DOI: 10.2174/1389450120666190222181857. View

18.

Kaan H, Chan S, Tan S, Guo F, Lim C, Hong W . Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex. Sci Rep. 2017; 7(1):2035. PMC: 5435683. DOI: 10.1038/s41598-017-02219-9. View

19.

Willers H, Azzoli C, Santivasi W, Xia F . Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J. 2013; 19(3):200-7. PMC: 3668666. DOI: 10.1097/PPO.0b013e318292e4e3. View

20.

Johnson R, Halder G . The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2013; 13(1):63-79. PMC: 4167640. DOI: 10.1038/nrd4161. View